146 related articles for article (PubMed ID: 35737155)
1. Prediction of EVT6-NTRK3-Dependent Papillary Thyroid Cancer Using Minor Expression Profile.
Kechin AA; Ivanov AA; Kel AE; Kalmykov AS; Oskorbin IP; Boyarskikh UA; Kharpov EA; Bakharev SY; Oskina NA; Samuilenkova OV; Vikhlyanov IV; Kushlinskii NE; Filipenko ML
Bull Exp Biol Med; 2022 Jun; 173(2):252-256. PubMed ID: 35737155
[TBL] [Abstract][Full Text] [Related]
2. Identification of Chimeric NTRK3 Genes in Papillary Thyroid Cancer Cells by Analyzing the Imbalance of the Expression of 5' and 3' mRNA Fragments.
Oskorbin IP; Ivanov AA; Smertina MA; Demidova IA; Boyarskikh UA; Kechin AA; Bakharev SY; Samuilenkova OV; Vihlyanov IV; Kushlinskii NE; Filipenko ML
Bull Exp Biol Med; 2023 Jun; 175(2):239-244. PubMed ID: 37477743
[TBL] [Abstract][Full Text] [Related]
3.
Bastos AU; de Jesus AC; Cerutti JM
Eur J Endocrinol; 2018 Jan; 178(1):83-91. PubMed ID: 29046324
[TBL] [Abstract][Full Text] [Related]
4. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.
Prasad ML; Vyas M; Horne MJ; Virk RK; Morotti R; Liu Z; Tallini G; Nikiforova MN; Christison-Lagay ER; Udelsman R; Dinauer CA; Nikiforov YE
Cancer; 2016 Apr; 122(7):1097-107. PubMed ID: 26784937
[TBL] [Abstract][Full Text] [Related]
5. Detection of NTRK1/3 Rearrangements in Papillary Thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing.
Lee YC; Chen JY; Huang CJ; Chen HS; Yang AH; Hang JF
Endocr Pathol; 2020 Dec; 31(4):348-358. PubMed ID: 32880785
[TBL] [Abstract][Full Text] [Related]
6. ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer.
Leeman-Neill RJ; Kelly LM; Liu P; Brenner AV; Little MP; Bogdanova TI; Evdokimova VN; Hatch M; Zurnadzy LY; Nikiforova MN; Yue NJ; Zhang M; Mabuchi K; Tronko MD; Nikiforov YE
Cancer; 2014 Mar; 120(6):799-807. PubMed ID: 24327398
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features and immunohistochemical utility of NTRK-, ALK-, and ROS1-rearranged papillary thyroid carcinomas and anaplastic thyroid carcinomas.
Nozaki Y; Yamamoto H; Iwasaki T; Sato M; Jiromaru R; Hongo T; Yasumatsu R; Oda Y
Hum Pathol; 2020 Dec; 106():82-92. PubMed ID: 32980422
[TBL] [Abstract][Full Text] [Related]
8. Development of a Cell Line Containing the Chimeric ETV6-NTRK3 Gene. The Search for Mutations of the Tyrosine Kinase Chimeric Domain That Cause Resistance to Larotrectinib.
Boyarskikh UA; Savostyanova TA; Oscorbin IP; Filipenko ML
Bull Exp Biol Med; 2023 May; 175(1):132-137. PubMed ID: 37338765
[TBL] [Abstract][Full Text] [Related]
9. The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation.
Tognon C; Garnett M; Kenward E; Kay R; Morrison K; Sorensen PH
Cancer Res; 2001 Dec; 61(24):8909-16. PubMed ID: 11751416
[TBL] [Abstract][Full Text] [Related]
10. Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions.
Hechtman JF; Benayed R; Hyman DM; Drilon A; Zehir A; Frosina D; Arcila ME; Dogan S; Klimstra DS; Ladanyi M; Jungbluth AA
Am J Surg Pathol; 2017 Nov; 41(11):1547-1551. PubMed ID: 28719467
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of the methods for detecting NTRK gene fusion variations in papillary thyroid carcinoma].
Jiang YY; Chen H; Xu BL; Wang S
Zhonghua Bing Li Xue Za Zhi; 2022 Aug; 51(8):726-732. PubMed ID: 35922162
[No Abstract] [Full Text] [Related]
12. [Clinicopathological features of NTRK3 gene rearrangement papillary thyroid carcinoma].
Li HQ; Chen XY; Yu XB; Chen LY; Zhang X; Jin L; Wu ZZ; Chen Z
Zhonghua Bing Li Xue Za Zhi; 2022 Feb; 51(2):126-131. PubMed ID: 35152631
[No Abstract] [Full Text] [Related]
13. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25).
Eguchi M; Eguchi-Ishimae M; Tojo A; Morishita K; Suzuki K; Sato Y; Kudoh S; Tanaka K; Setoyama M; Nagamura F; Asano S; Kamada N
Blood; 1999 Feb; 93(4):1355-63. PubMed ID: 9949179
[TBL] [Abstract][Full Text] [Related]
14.
Pekova B; Sykorova V; Dvorakova S; Vaclavikova E; Moravcova J; Katra R; Astl J; Vlcek P; Kodetova D; Vcelak J; Bendlova B
Thyroid; 2020 Dec; 30(12):1771-1780. PubMed ID: 32495721
[No Abstract] [Full Text] [Related]
15. Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors.
Rudzinski ER; Lockwood CM; Stohr BA; Vargas SO; Sheridan R; Black JO; Rajaram V; Laetsch TW; Davis JL
Am J Surg Pathol; 2018 Jul; 42(7):927-935. PubMed ID: 29683818
[TBL] [Abstract][Full Text] [Related]
16. Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers.
Ricarte-Filho JC; Li S; Garcia-Rendueles ME; Montero-Conde C; Voza F; Knauf JA; Heguy A; Viale A; Bogdanova T; Thomas GA; Mason CE; Fagin JA
J Clin Invest; 2013 Nov; 123(11):4935-44. PubMed ID: 24135138
[TBL] [Abstract][Full Text] [Related]
17. NTRK Gene Fusion Detection in Atypical Spitz Tumors.
Cappellesso R; Nozzoli F; Zito Marino F; Simi S; Castiglione F; De Giorgi V; Cota C; Senetta R; Scognamiglio G; Anniciello AM; Cesinaro AM; Mandalà M; Gianatti A; Valente MG; Valeri B; Sementa AR; Ricci C; Corti B; Roviello G; Dei Tos AP; Franco R; Massi D
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830218
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies.
Taylor J; Pavlick D; Yoshimi A; Marcelus C; Chung SS; Hechtman JF; Benayed R; Cocco E; Durham BH; Bitner L; Inoue D; Chung YR; Mullaney K; Watts JM; Diamond EL; Albacker LA; Mughal TI; Ebata K; Tuch BB; Ku N; Scaltriti M; Roshal M; Arcila M; Ali S; Hyman DM; Park JH; Abdel-Wahab O
J Clin Invest; 2018 Aug; 128(9):3819-3825. PubMed ID: 29920189
[TBL] [Abstract][Full Text] [Related]
19. Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing.
Bourhis A; Caumont C; Quintin-Roué I; Magro E; Dissaux G; Remoué A; Le Noac'h P; Douet-Guilbert N; Seizeur R; Tyulyandina A; Schick U; Merlio JP; Marcorelles P; Cappellen D; Uguen A
Pathology; 2022 Feb; 54(1):55-62. PubMed ID: 34518039
[TBL] [Abstract][Full Text] [Related]
20. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells.
Wai DH; Knezevich SR; Lucas T; Jansen B; Kay RJ; Sorensen PH
Oncogene; 2000 Feb; 19(7):906-15. PubMed ID: 10702799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]